Hutchison MediPharma Limited-Product Pipeline Review-2015

Hutchison MediPharma Limited-Product Pipeline Review-2015

  • Products Id :- GMDHC07425CDB
  • |
  • Pages: 49
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hutchison MediPharma Limited-Product Pipeline Review-2015


Global Markets Direct's, 'Hutchison MediPharma Limited-Product Pipeline Review-2015', provides an overview of the Hutchison MediPharma Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hutchison MediPharma Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Hutchison MediPharma Limited including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Hutchison MediPharma Limited's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Hutchison MediPharma Limited's pipeline products

Reasons To Buy

Evaluate Hutchison MediPharma Limited's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Hutchison MediPharma Limited in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Hutchison MediPharma Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Hutchison MediPharma Limited and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hutchison MediPharma Limited

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Hutchison MediPharma Limited and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Hutchison MediPharma Limited Snapshot 6

Hutchison MediPharma Limited Overview 6

Key Information 6

Key Facts 6

Hutchison MediPharma Limited-Research and Development Overview 7

Key Therapeutic Areas 7

Hutchison MediPharma Limited-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Hutchison MediPharma Limited-Pipeline Products Glance 12

Hutchison MediPharma Limited-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Hutchison MediPharma Limited-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Hutchison MediPharma Limited-Early Stage Pipeline Products 15

IND/CTA Filed Products/Combination Treatment Modalities 15

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

Hutchison MediPharma Limited-Drug Profiles 18

HMPL-013 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

HMPL-504 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

HMPL-012 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

HMPL-309 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

HMPL-523 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

HMPL-813 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

HM-029 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

HM-032 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

HM-5016699 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

HMPL-453 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

HMPL-507 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

HMPL-689 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

HMPL-518 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Hutchison MediPharma Limited-Pipeline Analysis 34

Hutchison MediPharma Limited-Pipeline Products by Target 34

Hutchison MediPharma Limited-Pipeline Products by Route of Administration 36

Hutchison MediPharma Limited-Pipeline Products by Molecule Type 37

Hutchison MediPharma Limited-Pipeline Products by Mechanism of Action 38

Hutchison MediPharma Limited-Recent Pipeline Updates 40

Hutchison MediPharma Limited-Dormant Projects 46

Hutchison MediPharma Limited-Locations And Subsidiaries 47

Head Office 47

Other Locations & Subsidiaries 47

Appendix 48

Methodology 48

Coverage 48

Secondary Research 48

Primary Research 48

Expert Panel Validation 48

Contact Us 48

Disclaimer 49

List of Tables

Hutchison MediPharma Limited, Key Information 6

Hutchison MediPharma Limited, Key Facts 6

Hutchison MediPharma Limited-Pipeline by Indication, 2015 8

Hutchison MediPharma Limited-Pipeline by Stage of Development, 2015 10

Hutchison MediPharma Limited-Monotherapy Products in Pipeline, 2015 11

Hutchison MediPharma Limited-Phase III, 2015 12

Hutchison MediPharma Limited-Phase II, 2015 13

Hutchison MediPharma Limited-Phase I, 2015 14

Hutchison MediPharma Limited-IND/CTA Filed, 2015 15

Hutchison MediPharma Limited-Preclinical, 2015 16

Hutchison MediPharma Limited-Discovery, 2015 17

Hutchison MediPharma Limited-Pipeline by Target, 2015 34

Hutchison MediPharma Limited-Pipeline by Route of Administration, 2015 36

Hutchison MediPharma Limited-Pipeline by Molecule Type, 2015 37

Hutchison MediPharma Limited-Pipeline Products by Mechanism of Action, 2015 39

Hutchison MediPharma Limited-Recent Pipeline Updates, 2015 40

Hutchison MediPharma Limited-Dormant Developmental Projects,2015 46

Hutchison MediPharma Limited, Other Locations 47

List of Figures

Hutchison MediPharma Limited-Pipeline by Top 10 Indication, 2015 8

Hutchison MediPharma Limited-Pipeline by Stage of Development, 2015 10

Hutchison MediPharma Limited-Monotherapy Products in Pipeline, 2015 11

Hutchison MediPharma Limited-Pipeline by Top 10 Target, 2015 34

Hutchison MediPharma Limited-Pipeline by Top 10 Route of Administration, 2015 36

Hutchison MediPharma Limited-Pipeline by Top 10 Molecule Type, 2015 37

Hutchison MediPharma Limited-Pipeline Products by Top 10 Mechanism of Action, 2015 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of Hutchison MediPharma Limited; Hutchison MediPharma Limited - Key Therapeutics; Hutchison MediPharma Limited - Pipeline Overview and Promising Molecules; Hutchison MediPharma Limited - News; Hutchison MediPharma Limited - Latest Updates; Hutchison MediPharma Limited - Pipeline; Hutchison MediPharma Limited - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101175
Site License
USD 3000 INR 202350
Corporate User License
USD 4500 INR 303525



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]